Insulinpumpe – ein Muss bei Schwangerschaften mit Typ 1 Diabetes?

Hauffe, F.; Sedlazek, L; Fauzan, R.; Schohe, A; Scholle, D; Klapp, C; Scherer, K; Henrich, Wolfgang; Abou-Dakn, Michael; Schäfer‐Graf, Ute

doi:10.1055/s-0037-1607811

Cited by 1 publication

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…But the results were mixed for pregnant women with diabetes. Some data showed a higher rate of large-for-gestational-age neonates in the CSII group compared with the MDI group [23], but there are also data suggesting similar glycemic control and no differences in pregnancy outcome [24]. For patients, there is no consensus on which form of insulin administration is best, but attention should be paid to individualized dose titration.…”

Section: Insulin Therapy In Dkd G3-5mentioning

confidence: 99%

Insulin therapy in diabetic kidney disease

Liu

Zhao

Xiong

et al. 2021

Diabetic Nephropathy

View full text Add to dashboard Cite

Diabetic kidney disease (DKD) is the main cause of end-stage renal disease (ESRD). The use of insulin represents a challenge in patients with DKD due to the patient and medication issues. Insulin regimens, insulin dosing, and titration need to be individualized based on the patient's age, renal function, and comorbidities to improve glycemic control and reduce the risk of hypoglycemia. Insulin is the primary treatment in all patients with type 1 diabetes mellitus (T1DM) and DKD. For patients with type 2 diabetes mellitus (T2DM) and early stage of DKD, basal insulin combined with oral antidiabetic drugs (OADs) is recommended. In patients with middle and advanced DKD, it is necessary to adjust the dose of insulin according to stages of DKD, and the use of insulin analogs is recommended. In particular, elderly patients with DKD can simplify their insulin regimen to reduce the risk of hypoglycemia. In pregnant women with DKD, insulin requirements also vary based on parity and the stage of pregnancy.

show abstract

Section: Insulin Therapy In Dkd G3-5mentioning

confidence: 99%